[Is all chronic neurosensory deafness irreversible?].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D001307:Auditory Perception; D001309:Auditory Threshold; D002648:Child; D002908:Chronic Disease; D003638:Deafness / Q000188:drug therapy* / Q000209:etiology; D004873:Ergolines / Q000627:therapeutic use; D004899:Erythroblastosis, Fetal / Q000150:complications; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007759:Labyrinth Diseases / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008353:Mannitol / Q000627:therapeutic use; D008575:Meniere Disease / Q000188:drug therapy; D008784:Methysergide / Q000627:therapeutic use; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D011247:Pregnancy; D014777:Virus Diseases / Q000150:complications
D004873:Ergolines; D009539:Nicotinic Acids; D008353:Mannitol; D000324:Adrenocorticotropic Hormone; D006493:Heparin; D008784:Methysergide
Les surdités neuosensorielles "chroniques" sont-elles toutes toutes irréversibles.